Prevalence, characteristics, and natural history of apical phenotype in a large cohort of patients with hypertrophic cardiomyopathy

Fananapazir, 1995, Prevalence of hypertrophic cardiomyopathy and limitations of screening methods, Circulation, 92, 700, 10.1161/01.CIR.92.4.700 Maron, 1995, Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults, Circulation, 92, 785, 10.1161/01.CIR.92.4.785 Guttmann, 2014, Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review, Heart, 100, 465, 10.1136/heartjnl-2013-304276 Marian, 2017, Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy, Circ Res, 121, 749, 10.1161/CIRCRESAHA.117.311059 Sakamoto, 1976, Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle. Echocardiographic and ultrasono-cardiotomographic study, Jpn Heart J, 17, 611, 10.1536/ihj.17.611 Hughes, 2020, Apical Hypertrophic Cardiomyopathy: The Variant Less Known, J Am Heart Assoc, 9 Flett, 2015, Diagnosis of apical hypertrophic cardiomyopathy: T-wave inversion and relative but not absolute apical left ventricular hypertrophy, Int J Cardiol, 183, 143, 10.1016/j.ijcard.2015.01.054 Moon, 2011, Clinical and echocardiographic predictors of outcomes in patients with apical hypertrophic cardiomyopathy, Am J Cardiol, 108, 1614, 10.1016/j.amjcard.2011.07.024 Sheikh, 2016, Comparison of hypertrophic cardiomyopathy in Afro-Caribbean versus white patients in the UK, Heart, 102, 1797, 10.1136/heartjnl-2016-309843 Towe, 2015, Genotype-Phenotype Correlations in Apical Variant Hypertrophic Cardiomyopathy, Congenit Heart Dis, 10, E139, 10.1111/chd.12242 Steinberg, 2020, Ventricular Arrhythmia in Septal and Apical Hypertrophic Cardiomyopathy: The French-Canadian Experience, Front Cardiovasc Med, 7, 10.3389/fcvm.2020.548564 Ommen, 2020, 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines, Circulation, 142, e558 Elliott, 2014, 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC), Eur Heart J, 35, 2733, 10.1093/eurheartj/ehu284 Richardson, 1996, Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies, Circulation, 93, 841, 10.1161/01.CIR.93.5.841 Kim, 2016, Differences in apical and non-apical types of hypertrophic cardiomyopathy: a prospective analysis of clinical, echocardiographic, and cardiac magnetic resonance findings and outcome from 350 patients, Eur Heart J Cardiovasc Imaging, 17, 678, 10.1093/ehjci/jev192 Lancellotti, 2013, Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging, Eur Heart J Cardiovasc Imaging, 14, 611, 10.1093/ehjci/jet105 Schiller, 1989, Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms, J Am Soc Echocardiogr, 2, 358, 10.1016/S0894-7317(89)80014-8 Yang, 2005, Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity, J Am Soc Echocardiogr, 18, 1074, 10.1016/j.echo.2005.06.011 Nagueh, 2022, J Am Soc Echocardiogr, 35, 533, 10.1016/j.echo.2022.03.012 Lee, 2021, Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy: Equivalent Detection by Magnetic Resonance Imaging and Contrast Echocardiography, J Am Soc Echocardiogr, 34, 1262, 10.1016/j.echo.2021.07.015 Walsh, 2007, Assessment of ventricular function with cardiovascular magnetic resonance, Cardiol Clin, 25, 15, 10.1016/j.ccl.2007.01.002 Spirito, 2000, Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy, N Engl J Med, 342, 1778, 10.1056/NEJM200006153422403 Maron, 2008, Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy, Circulation, 118, 1541, 10.1161/CIRCULATIONAHA.108.781401 Adabag, 2008, Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance, J Am Coll Cardiol, 51, 1369, 10.1016/j.jacc.2007.11.071 De Cobelli, 2009, Delayed-enhanced cardiac MRI for differentiation of Fabry's disease from symmetric hypertrophic cardiomyopathy, AJR Am J Roentgenol, 192, W97, 10.2214/AJR.08.1201 Takeda, 2013, MRI differentiation of cardiomyopathy showing left ventricular hypertrophy and heart failure: differentiation between cardiac amyloidosis, hypertrophic cardiomyopathy, and hypertensive heart disease, Jpn J Radiol, 31, 693, 10.1007/s11604-013-0238-0 Erz, 2013, Correlation between ECG abnormalities and cardiac parameters in highly trained asymptomatic male endurance athletes: evaluation using cardiac magnetic resonance imaging, Int J Cardiovasc Imag, 29, 325, 10.1007/s10554-012-0082-9 Sharma, 2000, Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes, J Am Coll Cardiol, 36, 864, 10.1016/S0735-1097(00)00816-0 Olivotto, 1999, Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy, J Am Coll Cardiol, 33, 2044, 10.1016/S0735-1097(99)00094-7 Sadoul, 1997, Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy, Circulation, 96, 2987, 10.1161/01.CIR.96.9.2987 Eriksson, 2002, Long-term outcome in patients with apical hypertrophic cardiomyopathy, J Am Coll Cardiol, 39, 638, 10.1016/S0735-1097(01)01778-8 Lip, 2015, Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry, Europace, 17, 1777, 10.1093/europace/euv269 Rowin, 2017, Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management, J Am Coll Cardiol, 69, 761, 10.1016/j.jacc.2016.11.063 Yang, 2020, Apical hypertrophic cardiomyopathy with left ventricular apical aneurysm: prevalence, cardiac magnetic resonance characteristics, and prognosis, Eur Heart J Cardiovasc Imaging, 21, 1341, 10.1093/ehjci/jeaa246 Kim, 2013, Long-term comparison of apical versus asymmetric hypertrophic cardiomyopathy, Int Heart J, 54, 207, 10.1536/ihj.54.207 Klarich, 2013, Risk of death in long-term follow-up of patients with apical hypertrophic cardiomyopathy, Am J Cardiol, 111, 1784, 10.1016/j.amjcard.2013.02.040 Zegkos, 2017, Atrial fibrillation in hypertrophic cardiomyopathy: A turning point towards increased morbidity and mortality, Hellenic J Cardiol, 58, 331, 10.1016/j.hjc.2017.01.027 Olivotto, 2012, Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging, Circ Heart Fail, 5, 535, 10.1161/CIRCHEARTFAILURE.112.967026 Yin, 2022, Clinical, echocardiographic and cardiac MRI predictors of outcomes in patients with apical hypertrophic cardiomyopathy, Int J Cardiovasc Imag, 38, 643, 10.1007/s10554-021-02430-w Yang, 2022, Apical aneurysm formation in apical hypertrophic cardiomyopathy: Pilot study with cardiac magnetic resonance, Int J Cardiol, 371, 480, 10.1016/j.ijcard.2022.09.024 Calabretta, 2022, Evaluation of stress myocardial blood flow patterns in patients with apical hypertrophic cardiomyopathy, J Nucl Cardiol, 29, 1946, 10.1007/s12350-022-02911-y Geske, 2013, B-type natriuretic peptide and survival in hypertrophic cardiomyopathy, J Am Coll Cardiol, 61, 2456, 10.1016/j.jacc.2013.04.004 Shirotani, 2020, B-type natriuretic peptide and outcome in patients with apical hypertrophic cardiomyopathy, J Cardiol, 76, 357 Itzhaki Ben Zadok, 2018, Calculated Risk for Sudden Cardiac Death in Patients with Apical Versus Nonobstructive Nonapical Hypertrophic Cardiomyopathy, Am J Cardiol, 122, 1551, 10.1016/j.amjcard.2018.07.014 Saito, 2022, Prognostic Relevance of a Score for Identifying Diastolic Dysfunction according to the 2016 American Society of Echocardiography/European Association of Cardiovascular Imaging Recommendations in Patients with Hypertrophic Cardiomyopathy, J Am Soc Echocardiogr, 35, 469, 10.1016/j.echo.2021.12.006 Maron, 2022, Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review, J Am Coll Cardiol, 79, 372, 10.1016/j.jacc.2021.12.002